Actively Recruiting
IV Fluids and Post-ERCP Pancreatitis
Led by University of Calgary · Updated on 2026-04-29
13000
Participants Needed
1
Research Sites
285 weeks
Total Duration
On this page
Sponsors
U
University of Calgary
Lead Sponsor
M
McGill University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Aggressive intravenous hydration has been shown in randomized trials to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), though studied regimens are often impractical. To date, no studies have prospectively assessed short-term (60-90 minute) aggressive hydration regimens that are feasible for outpatients undergoing ERCP and subsequent discharge. Furthermore, little is known with regard to fluid type, volume, and timing with respect to ERCP. In this study, we will aim to assess whether the amount of peri-procedural intravenous fluid administered around the time of ERCP is associated with the risk of PEP (the primary outcome).
CONDITIONS
Official Title
IV Fluids and Post-ERCP Pancreatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Referred for ERCP procedure, regardless of reason
- Age 18 years or older
- Able to give informed consent to participate
You will not qualify if you...
- Standard contraindication to ERCP procedure
- Unable or unwilling to provide informed consent
- Under 18 years of age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peter Lougheed Hospital
Calgary, Alberta, Canada
Actively Recruiting
Research Team
N
Nauzer Forbes, MD MSc
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here